[
    [
        {
            "time": "",
            "original_text": "【天风医药】迈瑞医疗：Q1扣非后归母净利润增长20-30%，业绩稳健向上",
            "features": {
                "keywords": [
                    "迈瑞医疗",
                    "Q1",
                    "扣非后归母净利润",
                    "增长20-30%",
                    "业绩稳健"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【天风医药】迈瑞医疗：Q1扣非后归母净利润增长20-30%，业绩稳健向上",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "【迈瑞医疗】Q1预告点评：业绩符合预期，三大板块齐头并进",
            "features": {
                "keywords": [
                    "迈瑞医疗",
                    "Q1",
                    "业绩符合预期",
                    "三大板块",
                    "齐头并进"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【迈瑞医疗】Q1预告点评：业绩符合预期，三大板块齐头并进",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "迈瑞医疗(300760)：业绩符合预期 收入利润均保持稳定快速增长",
            "features": {
                "keywords": [
                    "迈瑞医疗",
                    "300760",
                    "业绩符合预期",
                    "收入利润",
                    "稳定快速增长"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "迈瑞医疗(300760)：业绩符合预期 收入利润均保持稳定快速增长",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "医药生物行业跨市场周报:建议关注医药国改机会,港股医药配置价值凸显",
            "features": {
                "keywords": [
                    "医药生物行业",
                    "跨市场周报",
                    "医药国改",
                    "港股医药",
                    "配置价值"
                ],
                "sentiment_score": 0.75,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "医药生物行业跨市场周报:建议关注医药国改机会,港股医药配置价值凸显",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        }
    ]
]